Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Triamcinolone Acetonide for Alopecia Areata
NCT04412148Phase 4Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2020
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in alopecia areata, sponsored by Kasr Al Ainy Hospital. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04412148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04412148.